HS-/KN-Code 293790 ist für die EUDR-Vorbereitung außerhalb des Geltungsbereichs.
Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10) Die indexierte Scope-Engine liefert für diesen Code das Ergebnis Out of scope. No Annex I scope match was found for this indexed CN code.
Warum diese Referenzseite diese Antwort gibt.
- Code-Beschreibung
- Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)
- Anhang-I-Grundlage
- Kein direkter Anhang-I-Eintrag
- Quellengrundlage
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Übergeordnete, untergeordnete und benachbarte Zeilen.
Die Bibliotheksansicht dient der Referenznavigation. Nutzen Sie die HS-Code-Prüfung, wenn Sie einen weiteren Code aktiv prüfen möchten.
29organische chemische erzeugnissenarrower2937hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof "incl. chain modified polypeptides", used primarily as hormonesout29379000hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)(2012-2500);hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives)(2002-2011)out293710pituitary "anterior" or similar hormones, and derivatives, used primarily as hormonesout293711somatropin, its derivatives and structural analogues, used primarily as hormonesout293712insulin and its salts, used primarily as hormonesout293719polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)out293721cortisone, hydrocortisone, prednisone "dehydrocortisone" and prednisolone "dehydrohydrocortisone"out293722halogenated derivatives of corticosteroidal hormonesout
Was das für die Vorbereitung bedeutet.
Diese Zeile ist im aktuellen Geltungsbereichs-Ergebnis kein direkter Auslöser für die Nachweiserhebung.
Regulation (EU) 2023/1115 Annex I — relevant productsabgerufen am 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115abgerufen am 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)abgerufen am 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)abgerufen am 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8abgerufen am 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingabgerufen am 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersabgerufen am 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)abgerufen am 2026-08-08